期刊文献+

乳腺原位癌伴微小浸润的临床及病理学分析 被引量:6

Breast cancer in situ with microinvasion
原文传递
导出
摘要 目的总结和分析乳腺导管原位癌伴微小浸润(T_1 mic)的临床和组织病理特征,探讨合理的治疗方法。方法总结自1996年1月至2006年6月底共31名患者32例乳腺导管原位癌伴微小浸润的临床特征,组织病理特征,治疗方法及随访资料。结果经病理诊断的32例乳腺导管原位癌伴微小浸润患者中,最大浸润灶均≤1 mm,其中有27例(84%)临床上可触及肿块,有30例(93.8%)钼靶上有异常表现,病理可见粉刺样结构的病例为19例(59.4%),可见坏死的为20例(62.5%)。25例行腋窝淋巴结清扫术的患者没有一例有腋窝淋巴结转移。经过中位时间为28个月的随访无一例发生复发和转移。结论乳腺导管原位癌伴微小浸润是一个少见的乳腺癌亚型,其预后很好。治疗上应该根据其原位癌成分的病理特点及临床特征进行治疗。 Objective To analyze the clinical and pathological features of breast cancer in situ with microinvasion (T1 mic) and to seek for rationale managements. Methods Thirty-two breast cancer foci in 31 patients from January 1996 to June 2006 were diagnosed as T1 mic. We made an analysis on the clinical and pathological features, treatments and prognosis. Results The 32 T1 mic breast cancer tissues were all with invasive foci ≤ 1 mm. Among them, 27 cases ( 84% ) had palpable masses, 30 ( 93.75% ) presented mammographically-detected lesions, 19 ( 59.4% ) had comedo patterns and 20 ( 62.5% ) demonstrated necrosis. No lymph node metastasis was found in the 25 patients with axillary lymph node dissection. No patients had local recurrence and distant metastasis after a median follow-up of 38 months. Conclusion T1 mic is a less common type of breast carcinoma with extremely good prognosis. We should treat it according to its pathologic features of the accompanying carcinoma in situ and its clinical profiles.
出处 《中华普通外科杂志》 CSCD 北大核心 2007年第12期909-911,共3页 Chinese Journal of General Surgery
关键词 乳腺肿瘤 原位 微小浸润 Breast neoplasms Carcinoma in situ Microinvasion
  • 相关文献

参考文献1

共引文献66

同被引文献85

  • 1韦佳明,刘治滨.乳腺导管内癌的腋窝淋巴结转移率与术式选择[J].中国癌症杂志,2004,14(5):472-473. 被引量:5
  • 2陈凌,郭晓静,范宇,郎荣刚,臧凤琳,傅西林,付丽.乳腺微浸润癌的临床病理学特征及生物学特性[J].临床与实验病理学杂志,2006,22(5):526-530. 被引量:14
  • 3顾雅佳,肖勤,杨文涛,郑晓静,顾容丰.早期乳腺导管原位癌X线表现与预后生物学标记关系的研究[J].中华放射学杂志,2007,41(6):623-628. 被引量:9
  • 4Tang P,Hajdu SI,Lyman GH.Ductal carcinoma in situ:a review of recent advances.Curr Opin Obstet Gynecol,2007,19(1):63-67.
  • 5Silver SA,Tavassoli FA.Mammary ductal carcinoma in situ with microinvasion.Cancer,1998,82(12):2382-2390.
  • 6Silverstein MJ,Waisman JR,Gamagami P,et al.Intraductal carcinoma of the breast (208 cases).Clinical factors influencing treatment choice.Cancer,1990,66(1):102-108.
  • 7Lagios MD,Westdahl PR,Margolin FR,et al.Duct carcinoma insitu.Relationship of extent of noninvasive disease to the frequency of occult invasion,multicentricity,lymph node metastases,and short-term treatment failures.Cancer,1982,50(7):1309-1314.
  • 8Schuh ME,Nemoto T,Penetrante RB,et al.Intraductal carcinoma.Analysis of presentation,pathological findings,and outcome of disease.Arch Surg,1986,121(11):1303-1307.
  • 9Patchefsky AS,Schwartz GF,Finkelstein SD,et al.Heterogeneity of intraductal carcinoma of the breast.Cancer,1989,63 (4):731-741.
  • 10Rosner D,Lane WW,Penetrante R.Ductal carcinoma in situ with microinvasion.A curable entity using surgery alone without need for adjuvant therapy.Cancer,1991,67(6):1498-1503.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部